Cardiac Pacing Control Minimizing Ventricular Pauses After ATP Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Modern cardiac pacing devices experience ventricular pauses that are longer than the programmed lower rate interval (LRI) after switching from atrial anti-tachycardia pacing (ATP) therapy mode to a standard pacing mode, leading to undesirable symptoms, potential pro-arrhythmic effects, and confusion in patient data interpretation.
Innovation Solution
A pacing control system that adjusts the timing of pacing pulses in both the atrium and ventricle to minimize ventricular pauses by calculating and optimizing the atrial and ventricular activity durations during ATP therapy, allowing for adjustments in the number of ATP pulses, mean A-A interval, initial V-A interval, and V-V interval to synchronize the last ventricular pulse with the last ATP pulse.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the pacing device switches from therapy mode to non-tracking AV sequential mode after ATP therapy, then the device returns to standard pacing operation, but a long ventricular pause occurs that is greater than the programmed lower rate interval
Solution Approach 1:
The pacing control delivers a preliminary ventricular pacing pulse before the scheduled ventricular pulse timing to preemptively address the potential long pause. This preliminary action ensures that the ventricular rate remains within the programmed lower rate interval even when transitioning from ATP therapy mode to non-tracking mode, preventing the harmful ventricular pause from occurring.
2Ease of operation
If the ventricle is paced independent of atrial activity during ATP therapy, then ATP therapy can be delivered effectively, but the transition back to AV sequential mode creates ventricular pauses
Solution Approach 1:
The pacing control applies preliminary anti-action by delivering a ventricular pacing pulse that counteracts the impending long pause before it can occur. When transitioning from ATP therapy mode where ventricular pacing is independent, the system proactively delivers a pulse to prevent the harmful effect of ventricular pause that would otherwise result from the mode transition to AV sequential pacing.
3Productivity
If the last atrial pulse occurs immediately prior to the next scheduled ventricular pulse, then ATP therapy timing is optimized, but the V-V interval becomes significantly longer than the lower rate interval
Solution Approach 1:
The pacing control delivers a preliminary ventricular pacing pulse to compensate for the timing conflict. When the last ATP pulse is scheduled to occur immediately before the next ventricular pulse, the system proactively delivers an additional ventricular pulse to ensure the V-V interval does not exceed the programmed lower rate interval, thereby preventing the harmful long pause while maintaining ATP therapy efficiency.
Data Source
AI summary
A pacing control is used in a multiple-chamber cardiac pacing system, which, upon detecting an atrial arrhythmia, automatically switches to a special therapy mode and administers a selected anti-tachycardia pacing (ATP) therapy in the atrium, and which switches to a standard pacing mode following delivery of the ATP therapy. The pacing control adjusts the timing of pacing pulses to be delivered to the atrium and/or the ventricle to minimize any potential ventricular pauses that may result from the switch from the therapy mode to the standard pacing mode.